Product Information

ENOXAPARIN 300 MG/3 ML VIAL is a generic product labeled by BluePoint Laboratories, priced at $10.2663 per ML under NDC 68001046441. Its NADAC has been published 217 times since Mar 31, 2021.

FDA first approved this application on Mar 14, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ENOXAPARIN 300 MG/3 ML VIAL

enoxaparin sodium
$10.2663per ML

Strength

300 mg/3mL

NDC

68001046441

Classification

Generic

Dosage Form

INJECTION

Route

INTRAVENOUS; SUBCUTANEOUS

Effective Date

8/19/2026

Active Ingredients

ENOXAPARIN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA208600

FDA Approved

3/14/2019

TE Code

AB

On Market Since

10/19/2020

Pharmacological Classes

Heparin
Low-Molecular-Weight
Low Molecular Weight Heparin

Price Statistics

The NADAC for ENOXAPARIN 300 MG/3 ML VIAL has been published 217 times since Mar 31, 2021, and over the history we have for it it has declined 17.9%. The table below summarizes its recorded NADAC range and movement.

Current price$10.2663 per ML
All-time high$13.4280 (Jun 14, 2023)
All-time low$9.8758 (Jun 17, 2026)
52-week high$11.6405
52-week low$9.8758
Median price$11.7748
Average price$11.9113
Largest weekly change-9.1% (Apr 17, 2024)
Weeks tracked217
Tracking sinceMar 31, 2021

Price History

1W

+3.4%

1M

+3.4%

3M

+0.8%

6M

-4.5%

1Y

-9.0%

3Y

-23.5%

5Y

-17.9%

All

-17.9%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ENOXAPARIN 300 MG/3 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for ENOXAPARIN 300 MG/3 ML VIAL, manufactured by BluePoint Laboratories, is $10.2663 per ML (NDC 68001046441), effective Aug 19, 2026.

How has the price of ENOXAPARIN 300 MG/3 ML VIAL changed over time?

Over the history we have for it, the NADAC for ENOXAPARIN 300 MG/3 ML VIAL has declined 17.9%. It has been tracked across 217 weekly CMS publications since Mar 31, 2021.

What are the highest and lowest recorded NADAC prices for ENOXAPARIN 300 MG/3 ML VIAL?

Since Mar 31, 2021, the NADAC for ENOXAPARIN 300 MG/3 ML VIAL has ranged from a low of $9.8758 (Jun 17, 2026) to a high of $13.4280 (Jun 14, 2023), with a median of $11.7748 per ML.

Are there cheaper alternatives to ENOXAPARIN 300 MG/3 ML VIAL?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ENOXAPARIN 300 MG/3 ML VIAL in a comparable dosage form, but none are currently priced below it.

Who manufactures ENOXAPARIN 300 MG/3 ML VIAL?

ENOXAPARIN 300 MG/3 ML VIAL (NDC 68001046441) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.